More about

Headache

News
January 04, 2022
1 min read
Save

Integrated infusion care models may be effective for pediatric refractory headache

An integrated ambulatory care model that had infusion capacity for pediatric refractory headache appeared feasible and beneficial for these patients, according to a quality improvement study.

News
January 03, 2022
1 min read
Save

Top neuro stories of 2021: Aduhelm news, neurologic COVID-19 symptoms

Healio Neurology’s most-viewed stories from 2021 highlight developments surrounding Aduhelm, the benefits of flavonoid on cognitive function and neurologic symptoms in COVID-19.

News
November 01, 2021
1 min read
Save

Reyvow, Nurtec ODT, Ubrelvy may be alternatives for acute migraine treatment

Reyvow, Nurtec ODT, Ubrelvy may be alternatives for acute migraine treatment

Reyvow, Nurtec ODT and Ubrelvy were less efficacious than triptans for treating migraines, but these new pharmacologic agents correlated with fewer adverse events, according to a study published in JAMA Network Open.

News
October 21, 2021
2 min read
Save

Availability of alternative pain treatment decreased opioid use

Availability of alternative pain treatment decreased opioid use

The likelihood that opioid treatment for common neurological conditions was initiated appeared to decrease with greater access to neurologists or other specialists who offered alternative pain treatment.

News
October 18, 2021
2 min read
Save

Mindfulness-based stress reduction has long-lasting benefits for migraine

Mindfulness-based stress reduction has long-lasting benefits for migraine

Mindfulness-based stress reduction appeared to safely treat total migraine burden with long-lasting effects, according to findings presented at the annual meeting of the American Neurological Association.

News
August 20, 2021
2 min read
Save

Oral atogepant reduces monthly migraine, headache

Oral atogepant reduces monthly migraine, headache

Oral atogepant once per day effectively decreased the number of migraine and headache days over 12 weeks, according to findings from the phase 3 ADVANCE trial that were published in The New England Journal of Medicine.

News
June 09, 2021
2 min read
Save

Novel nerve stimulation device provides migraine pain relief

Novel nerve stimulation device provides migraine pain relief

Cefaly Technology’s nerve stimulation device, when compared with sham stimulation, was more effective in delivering pain relief and freedom from most bothersome migraine symptom, phase 3 trial data show.

News
June 08, 2021
1 min read
Save

Nitrates top list of medications that trigger headaches, analysis shows

Nitrates top list of medications that trigger headaches, analysis shows

Nitrates were the most frequent cause of medication-induced headaches, according to an analysis of more than 2.6 million records in the FDA’s Adverse Event Reporting System.

News
June 08, 2021
3 min read
Save

Headache, mood disorders increase among pediatric patients during COVID-19 pandemic

Headache, mood disorders increase among pediatric patients during COVID-19 pandemic

Pediatric patients with headache experienced increased headache frequency, poorer anxiety and mood, less physical activity and more screen time during the COVID-19 pandemic, despite reported improvements in hydration, sleep and diet.

News
June 04, 2021
2 min read
Save

Fremanezumab demonstrates efficacy, safety for migraine

Researchers observed no statistically significant differences between Ajovy and placebo for the treatment of posttraumatic headache among adults enrolled in a phase 2 study that evaluated the safety and efficacy of Ajovy.

View more